title: Cerebral amyloid burden and Alzheimer's disease subtypes--does localization information matter?
authors.affiliation: Clinical Neurochemistry Laboratory, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden. henrik.zetterberg@gu.se.|UCL Institute of Neurology, Queen Square, London, UK. henrik.zetterberg@gu.se.
authors.forename: H
authors.initials: H
authors.lastname: Zetterberg
authors.affiliation: Clinical Memory Research Unit, Lund University, Lund, Sweden.
authors.forename: N
authors.initials: N
authors.lastname: Mattsson
mesh_terms: D000544:Alzheimer Disease; D016229:Amyloid beta-Peptides / Q000378:metabolism*; D001921:Brain / Q000378:metabolism; D006801:Humans; D049268:Positron-Emission Tomography
chemical_list: D016229:Amyloid beta-Peptides